6GV-13755-15338
3 vaccinations
2 coded responses
16 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 442 / OH
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
ZW5-28197-42133
Child or adolescent in my care · Male · 2022-07-18
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Moderna
- 2020-12-31
-
2021-01-01
Survey response — days 1–6 daily, dose 1MedDRA: Respiratory tract congestion — Feeling: Good · Site: PainFree text: CongestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-02
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-07
-
2021-01-14
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site urticaria — Feeling: GoodFree text: Injection site redness and inching and raised skin/swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-23
-
2021-01-28
Dose 2 — Moderna
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-07-29
-
2021-10-30
Dose 3 — Moderna
- 2022-01-28
- 2022-05-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-01-28 | Moderna | |
| 3 | 2021-10-30 | Moderna | No |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Congestion
Release 2 — day 14, dose 1
Symptoms: Injection site redness and inching and raised skin/swelling
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Injection site urticaria | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release